Moleculin Biotech (MBRX) EBITDA (2015 - 2026)
Moleculin Biotech (MBRX) EBITDA from Sep 30, 2015 to Mar 31, 2026. The TTM Moleculin Biotech (MBRX) EBITDA is -$27M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Moleculin Biotech (MBRX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +4.62% |
| 3 Years TTM | -5.35% |
| 5 Years TTM | +5.57% |
| 10 Years TTM | +47.85% |
| All Time TTM | +28.67% |
Annual EBITDA change of Moleculin Biotech (MBRX)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$7.87M | -68.53% |
| 2025 | -$25M | -5.66% |
| 2024 | -$27M | -10.14% |
| 2023 | -$30M | -3.31% |
| 2022 | -$31M | +33.82% |
| 2021 | -$23M | +16.68% |
| 2020 | -$20M | +12.82% |
| 2019 | -$17M | +15.78% |
| 2018 | -$15M | +73.35% |
| 2017 | -$8.63M | +122.42% |
| 2016 | -$3.88M | +1663.64% |
| 2015 | -$220K | N/A |
Comparison Moleculin Biotech (MBRX) five years EBITDA CAGR with competitors
Moleculin Biotech (MBRX) five years EBITDA CAGR is 5.56%.